title: Roots of clinical resistance to STI-571 cancer therapy.
authors.affiliation: III. Medizinische Universitätsklinik, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg, Mannheim, Germany. hochhaus@uni-hd.de
authors.forename: A
authors.initials: A
authors.lastname: Hochhaus
authors.forename: S
authors.initials: S
authors.lastname: Kreil
authors.forename: A
authors.initials: A
authors.lastname: Corbin
authors.forename: P
authors.initials: P
authors.lastname: La Rosée
authors.forename: T
authors.initials: T
authors.lastname: Lahaye
authors.forename: U
authors.initials: U
authors.lastname: Berger
authors.forename: N C
authors.initials: NC
authors.lastname: Cross
authors.forename: W
authors.initials: W
authors.lastname: Linkesch
authors.forename: B J
authors.initials: BJ
authors.lastname: Druker
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
authors.forename: C
authors.initials: C
authors.lastname: Gambacorti- Passerini
authors.forename: G
authors.initials: G
authors.lastname: Corneo
authors.forename: M
authors.initials: M
authors.lastname: D'Incalci
mesh_terms: D019943:Amino Acid Substitution; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D016044:Fusion Proteins, bcr-abl / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D010879:Piperazines / Q000627:therapeutic use*; D017354:Point Mutation; D016315:Proto-Oncogene Proteins c-abl / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; D016315:Proto-Oncogene Proteins c-abl